对于患有严重喘的患者来说,tezepelumab的定位:从证据到未满足的需求
Carlo Lombardi1, Marcello Cottini2, Annamaria Bosi3
1Departmental Unit of Allergology, Clinical Immunology & Pneumology, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy.
The Journal of international medical research
|November 18, 2024
概括
用tzepelumab (TZP) 阻断胸膜 stromal lymphopoietin (TSLP) 显示出对缺乏2型炎症的严重喘有希望. 这种生物药物为难以治疗的喘患者提供了一种安全有效的新疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的喘表现出多种不同的内型,非2型炎症的理解很差,并且对标准疗法有抗性.
- 表皮屏障功能障碍释放了警示蛋白,如胸膜 stromal 淋巴蛋白 (TSLP),IL-25和IL-33,驱动炎症.
- TSLP是严重喘发病的关键媒介,使其成为新型治疗的目标.
研究的目的:
- 审查用于治疗严重喘的tzepelumab (TZP) 的证据.
- 分析关于TZP疗效和安全性的临床试验数据.
- 为指导临床医生选择适合TZP治疗的患者提供指导.
主要方法:
- 现有文献和临床试验数据的叙述性综述.
- 对TSLP在严重喘中的作用的分析.
- 评估tzepelumab的作用机制和临床结果.
主要成果:
- 捷佩卢马布 (TZP) 有效地阻断TSLP,TSLP是严重喘中关键的细胞因子.
- 临床试验表明TZP是一种有前途,安全和有效的治疗方法.
- 在各种严重喘表型中,TZP提供了潜在的好处.
结论:
- 捷佩卢马布 (TZP) 代表了严重喘管理的重大进展,特别是在治疗选择有限的患者中.
- 了解TSLP的作用对于优化TZP治疗至关重要.
- 对患者选择的进一步洞察将最大限度地提高TZP的治疗影响.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:17Drugs Used in Lower Respiratory Disorders: Overview
353
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
353
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
234
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
234
01:24Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K